Prevention of mother-to-child transmission of hepatitis B virus: A phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen

• Main Authors: Jourdain G., Ngo-Giang-Huong N., Cressey T., Hua L., Harrison L., Tierney C., Salvadori N., Decker L., Traisathit P., Sirirungsi W., Khamduang W., Bowonwatanuwong C., Puthanakit T., Siberry G., Watts D., Murphy T., Achalapong J., Hongsiriwon S., Klinbuayaem V., Thongsawat S., Chung R., Pol S., Chotivanich N.
• Format: Journal
• Published: 2017
• Online Access: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84981186408&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/41657
• Institution: Chiang Mai University

© 2016 The Author(s). Background: Chronic hepatitis B virus (HBV) infection is complicated by cirrhosis and liver cancer. In Thailand, 6-7 % of adults are chronically infected with HBV. The risk of mother-to-child transmission (MTCT) of HBV has been estimated to be about 12 % when mothers have a hig...